Correlation Between Akeso, and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akeso, and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akeso, and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akeso, Inc and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Akeso, and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akeso, with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akeso, and Arrowhead Pharmaceuticals.

Diversification Opportunities for Akeso, and Arrowhead Pharmaceuticals

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Akeso, and Arrowhead is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Akeso, Inc and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Akeso, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akeso, Inc are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Akeso, i.e., Akeso, and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akeso, and Arrowhead Pharmaceuticals

Assuming the 90 days horizon Akeso, Inc is expected to generate 1.12 times more return on investment than Arrowhead Pharmaceuticals. However, Akeso, is 1.12 times more volatile than Arrowhead Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest  700.00  in Akeso, Inc on December 30, 2024 and sell it today you would earn a total of  200.00  from holding Akeso, Inc or generate 28.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.38%
ValuesDaily Returns

Akeso, Inc  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
Akeso, Inc 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akeso, Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Akeso, reported solid returns over the last few months and may actually be approaching a breakup point.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Akeso, and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akeso, and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Akeso, and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akeso, position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind Akeso, Inc and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios